Colorado Springs, Colorado 2021-09-17 16:39:12 –
The Food and Drug Administration (FDA) Advisory Board voted 18-0 to approve Pfizer booster shots for Americans over the age of 65 and Americans at risk of severe COVID-19 infection.
The Panel also voted to approve booster shots for people at serious COVID-19 risk for their work, including healthcare workers, teachers, and essential infrastructure workers.
In a blow to President Joe Biden’s vaccine program, the panel previously voted not to approve booster shots for all Americans.
Biden had previously said that booster shots would be available to Americans by September 20th.
of Data released by the FDA on Wednesday, Pfizer argued that vaccine booster shots are not only safe and effective, but also necessary for all Americans over the age of 16.
The data also showed that the third vaccination restored the preventive effect of COVID-19 by up to 95%.
Associated Press The panel complained that Pfizer provided little data on the safety of additional doses and that even if all Americans were offered booster shots, it would not dramatically change the pandemic arc. It is reported that it was done.
The Centers for Disease Control and Prevention will meet next week to review the panel’s decisions.
FDA panel approves COVID-19 booster for 65 and older Source link FDA panel approves COVID-19 booster for 65 and older